Quaker Houghton appoints new executives to drive growth strategy

CONSHOHOCKEN, Pa. - Quaker Houghton (NYSE:KWR), a $2.3 billion market cap industrial process fluids company with annual revenues of $1.8 billion and a "GOOD" financial health rating according to InvestingPro, announced on Wednesday two executive leadership appointments aimed at supporting the company’s strategic priorities and growth initiatives.

Christine Johnson has joined the industrial process fluids company as Senior Vice President and Chief Transformation Officer, while Dr. André Frodl, a 23-year veteran of the organization, has been promoted to Vice President, R&D - Metals and Metalworking.

Johnson, who previously served as a partner at McKinsey & Company where she advised materials and energy companies, will lead transformation and process optimization efforts across the organization. Before McKinsey, she held digital marketing and communications leadership positions at DuPont.

Frodl will oversee research and development for the company’s metals, metalworking, and operating solutions business globally. He succeeds Dr. Dave Slinkman, who recently retired. Frodl’s responsibilities include managing lab functions such as product stewardship, fluid analysis, and analytical and raw material chemistry.

"Their leadership will be vital as we advance our strategic priorities and continue delivering innovative solutions to our customers," said Joe Berquist, Chief Executive Officer and President, in the press release.

Quaker Houghton describes itself as the global leader in industrial process fluids with operations in over 25 countries and approximately 4,400 employees worldwide. The company serves customers in industries including steel, aluminum, automotive, aerospace, and metalworking.

In other recent news, Quaker Chemical Corporation reported its second-quarter 2025 earnings, with earnings per share (EPS) of $1.71, which did not meet analysts’ expectations of $1.86, marking a negative surprise of 8.06%. However, the company achieved a revenue of $483.4 million, exceeding the forecast of $462.13 million and resulting in a positive revenue surprise of 4.6%. In terms of analyst activity, Jefferies adjusted its price target for Quaker Chemical from $167 to $164 while maintaining a Buy rating on the stock. The firm highlighted challenging organic growth conditions as a concern, predicting that share gains could become a significant topic of discussion among investors in the coming months. These developments represent the latest updates on Quaker Chemical’s financial performance and market outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.